Sildenafil citrate and tamsulosin combination is not superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction

Tuncel A., Nalcacioglu V., Ener K., Aslan Y., Aydin O., Atan A.

WORLD JOURNAL OF UROLOGY, cilt.28, sa.1, ss.17-22, 2010 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 28 Sayı: 1
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1007/s00345-009-0484-z
  • Dergi Adı: WORLD JOURNAL OF UROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.17-22
  • Anahtar Kelimeler: Benign prostate hyperplasia, Lower urinary tract symptoms, Erectile dysfunction, Sildenafil citrate, Tamsulosin, BENIGN PROSTATIC HYPERPLASIA, SEXUAL FUNCTION, MEN, SECONDARY, TADALAFIL, EFFICACY
  • Gazi Üniversitesi Adresli: Hayır

Özet

To evaluate the efficacy of sildenafil citrate only, 25 mg. Four times/week, tamsulosin only, 0.4 mg once daily, and the combination of both on lower urinary tract symptoms (LUTS) suggestive of benign prostate hyperplasia (BPH) and erectile dysfunction.